title: Operating RegenMed: development of better in-theater strategies for handling tissue-engineered organs and tissues.
abstract: Tissue engineering ex vivo and direct cellular application with bioscaffolds in vivo has allowed surgeons to restore and establish function throughout the human body. The evidence for regenerative surgery is growing, and consequently there is a need for the development of more advanced regenerative surgery facilities. Regenerative medicine in the surgical field is changing rapidly and this must be reflected in the design of any future operating suite. The theater environment needs to be highly adaptable to account for future significant advances within the field. Development of purpose built, combined operating suites and tissue-engineering laboratories will provide the facility for modern surgeons to treat patients with organ deficits, using bespoke, regenerated constructs without the need for immunosuppression.
authors.affiliation: UCL Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Fishman
authors.forename: Justin C R
authors.initials: JC
authors.lastname: Wormald
authors.forename: Mark W
authors.initials: MW
authors.lastname: Lowdell
authors.forename: Paolo D E
authors.initials: PD
authors.lastname: Coppi
authors.forename: Martin A
authors.initials: MA
authors.lastname: Birchall
mesh_terms: D001187:Artificial Organs; D006801:Humans; D044968:Regenerative Medicine; D013043:Specialties, Surgical; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000166:cytology*; D023822:Tissue Engineering; D054457:Tissue Scaffolds
keywords: biotechnology; operating room; operating theater; reconstruction; regeneration; regenerative medicine; scaffold; stem cells; surgery; tissue engineering